ZFIN Image: Zhang et al., 2012, Fig. 3

Image

Figure Caption

Fig. 3

The phenotypes of irx7SMO and irx7MO2 morphants at 72 hpf.

Phenotypic analysis of the optimized irx7SMO (A–E) and irx7MO2 (F–J) injection experiments. (A) The lateral view of an uninjected control embryo for irx7SMO injection experiments. (B) An embryo injected with 10 ng of Control MO. (C–E) Three phenotypic categories of the morphants after injected with 10 ng of irx7SMO. The percentage of embryos that had mild (C), intermediate (D) and severe (E) phenotypes was 13.52% (N = 106), 69.81% (N = 444) and 16.67% (N = 86) respectively. (F) The lateral view of an uninjected control embryo for irx7MO2 injection experiments. (G) An embryo injected with 3 ng of irx7MO2-6 bms. (H–J) Three phenotypic categories of morphants after injected with 3 ng of irx7MO2. The percentage of embryos that had mild (H), intermediate (I), and severe (J) phenotypes were 13.28% (N = 38), 73.78% (N = 211) and 12.94% (N = 37) respectively. Scale bar = 200 μm.

Figure Data

Phenotype details

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ PLoS One